The Siteman Cancer Center is the only NCI-designated Comprehensive
Cancer Center in Missouri and within a 240-mile radius of St. Louis.
Siteman comprises all of the cancer-related programs of Washington University
School of Medicine and Barnes-Jewish Hospital. More than 350 Washington
University physicians and investigators affiliated with Siteman treat
over 6,000 newly diagnosed cancer patients each year and hold more than
$130 million in annual research and training grants. Siteman has approximately
350 active clinical studies and runs community and outreach programs
that touch more than 30,000 people each year.
The research in current and developing programs has resulted
in federally funded translational initiatives in nanotechnology, bioinformatics,
chemoprevention, pharmacogenetics, gene therapy, proteomics, imaging,
genomics, and leukemia and lymphoma, and more than 30 multiproject or
collaborative cancer grants are held by Siteman investigators. Siteman
is a funded developer in multiple areas of the NCI Cancer Biomedical
Informatics Grid (caBIG) project and has recently received NCI funding
through the Community Networks Program (CNP), Specialized Program for
the Evaluation of Cancer Signatures (SPECS), and Centers of Cancer Nanotechnology
Excellence (CCNE) programs.
|
